Irini Sereti
National Institutes of Health (NIH) · National Institute of Allergy and Infectious Diseases (NIAID) · National Institute for Allergy and Infectious Diseases, National Institutes of Health
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Registry trials as an overall official
16
all conditions, ClinicalTrials.gov
NIH grants tied to them
3
NIH RePORTER
Trial papers
41
PubMed author-name match
Trials
Studies that name Irini Sereti as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 05:52 UTC. Open this list on ClinicalTrials.gov
- N/ANCT06045923 · Virologic and Immunologic Characteristics of Severe Mpox in Persons With Advanced HIVCenters for Disease Control and Prevention · terminated · Monkeypox, HIV Infections, AIDS · study director
- N/ANCT05096091 · International Study on COVID-19 Vaccine to Assess Immunogenicity, Reactogenicity and Efficacy (InVITE)National Institute of Allergy and Infectious Diseases (NIAID) · completed · COVID-19 · study director
- N/ANCT04408950 · Sample Collection for Systems Evaluation of Patients With Unknown or Incompletely Characterized Immune DefectsNational Institute of Allergy and Infectious Diseases (NIAID) · completed · Immunodeficiency · principal investigator
- N/ANCT04401436 · COVID-19 Associated Lymphopenia Pathogenesis Study in BloodNational Institute of Allergy and Infectious Diseases (NIAID) · completed · Coronavirus Disease 2019 · principal investigator
- Ph1NCT04097561 · Safety of Belimumab in People With Idiopathic CD4 Lymphopenia and Autoantibodies (Phoebe)National Institute of Allergy and Infectious Diseases (NIAID) · recruiting · Idiopathic CD4 Lymphopenia · principal investigator
- Ph1NCT02652546 · CC-11050 in Human Immunodeficiency Virus-1-Infected Adults With Suppressed Plasma Viremia on Antiretroviral Therapy (APHRODITE)National Institute of Allergy and Infectious Diseases (NIAID) · completed · HIV, Inflammation · principal investigator
- N/ANCT02147405 · PET Imaging and Lymph Node Assessment of IRIS in People With AIDSNational Institute of Allergy and Infectious Diseases (NIAID) · recruiting · Immune Reconstitution Inflammatory Syndrome · principal investigator
- Ph2NCT02081638 · Elite Controller and ART-treated HIV+ Statin Versus ASA Treatment Intervention StudyNational Institute of Allergy and Infectious Diseases (NIAID) · completed · Human Immunodeficiency Virus · principal investigator
- Ph2NCT02015013 · Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine ModelsNational Institute of Allergy and Infectious Diseases (NIAID) · recruiting · Idiopathic CD4-Positive, T-Lymphocytopenia · principal investigator
- N/ANCT01611402 · Gene Expression in HIV and Tuberculosis Co-infectionNational Institute of Allergy and Infectious Diseases (NIAID) · completed · Tuberculosis · principal investigator
- N/ANCT00988780 · Maraviroc (CCR5) Antagonism to Decrease the Incidence of the Immune Reconstitution Inflammatory Syndrome in HIV-Infected PatientsInstituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran · unknown · Immune Reconstitution Inflammatory Syndrome, HIV, HIV Infections · principal investigator
- N/ANCT00867269 · Etiology, Pathogenesis, and Natural History of Idiopathic CD4+ LymphocytopeniaNational Institute of Allergy and Infectious Diseases (NIAID) · recruiting · Idiopathic CD4+ Lymphocytopenia, Cryptococcal Meningitis, Warts · principal investigator
- Ph1NCT00477321 · Safety Study of IL-7 in HIV-infected Patients (Inspire)Cytheris SA · completed · HIV Infections, Lymphopenia · study chair
- N/ANCT00286767 · Immune Reconstitution Syndrome in HIV-Infected Patients Taking Antiretroviral TherapyNational Institute of Allergy and Infectious Diseases (NIAID) · completed · Immune Reconstitution Inflammatory Syndrome · principal investigator
- Ph1NCT00099671 · Safety of Interleukin-7 in HIV Infected People Currently Taking Anti-HIV DrugsNational Institute of Allergy and Infectious Diseases (NIAID) · completed · HIV Infections · study chair
- Ph2NCT00071890 · Phase II/III Study Evaluating the Effect of IL-2 on Preservation of the CD4 T-Lymphocytes After Interruption of Antiretroviral Treatment in HIV-Infected Patients With CD4 T-Lymphocyte Count Greater Than 500 Cells/mm3 Who Received Antiretroviral TxNational Institute of Allergy and Infectious Diseases (NIAID) · completed · HIV Infections · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-12 05:52 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
- HIV patients produce IgM autoantibodies with anti-lymphocyte reactivities and complement-mediated lytic function that persist after anti-retroviral therapyZIAAI001409 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · fiscal years 2025 · $100,830 awarded in 2025Same name and institution; not confirmed by an ID
- Immunopathogenic Mechanisms of Human Immunodeficiency Virus (HIV) DiseaseZIAAI001121 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · fiscal years 2010 to 2025 · $1,470,482 awarded in 2025Same name and institution; not confirmed by an ID
- Role of lymphopenia and inflammation in COVID-19 pathogenesisZIAAI001308 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · fiscal years 2020 to 2024 · $162,051 awarded in 2024Same name and institution; not confirmed by an ID
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 05:52 UTC. The ranking covers the 200 most relevant of 41 PubMed records, and a shared surname and initials can bring in a namesake. All 41 on PubMed
- 975 citationsRCR 26.4
- 284 citationsRCR 6.0
- Higher levels of CRP, D-dimer, IL-6, and hyaluronic acid before initiation of antiretroviral therapy (ART) are associated with increased risk of AIDS or death.J Infect Dis · 2011275 citationsRCR 7.2
- Initiation of ART during early acute HIV infection preserves mucosal Th17 function and reverses HIV-related immune activation.PLoS Pathog · 2014236 citationsRCR 6.7
- 209 citationsRCR 5.6
- 193 citationsRCR 4.8
- 149 citationsRCR 3.6
- 122 citationsRCR 3.8
- In vivo expansion of CD4CD45RO-CD25 T cells expressing foxP3 in IL-2-treated HIV-infected patients.J Clin Invest · 2005110 citationsRCR 2.0
- Pomalidomide for Symptomatic Kaposi's Sarcoma in People With and Without HIV Infection: A Phase I/II Study.J Clin Oncol · 2016100 citationsRCR 3.3